Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI?
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Ibuprofen-induced unilateral optic neuritis.
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.
Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Can we safely target the WNT pathway?
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
A Randomized Controlled Trial of Cognitive Behavioral Therapy (CBT) for Adjusting to Multiple Sclerosis (the saMS Trial): Does CBT Work and for Whom Does It Work?
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
Psychiatric symptoms in patients with multiple sclerosis.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Pages